ETFsBloomberg MSCI ESG Euro Corporate 1-5 Year Select Index
Amundi

Amundi EUR Corporate Bond 1-5Y ESG UCITS ETF Acc

EBBB PAAccumulatingPhysical, full replicationLuxembourgNot PEA-eligible
Last close · EUR
54.98EUR
+0.07% · +€0.04
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
EBBBBase
Fund charges
0.20%Total expense ratio (TER)
Fund size
€6.4bnall share classes
Return 1Y
0.0%
Sharpe 3Y
0.33
Volatility 1Y
2.1%annualised
Holdings
1,859Fund holdings

Performance

Compare
  • EBBB0.0%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
EBBB+0.7%-0.3%+0.1%+0.1%0.0%+11.6%+4.7%
MSCI World+0.4%+4.9%+10.8%+16.3%+15.9%+75.5%+71.2%
Gap to MSCI World+0.2%-5.2%-10.7%-16.2%-15.9%-63.9%-66.5%

Risk and return

Sharpe ratio · 3Y
0.33
Below MSCI World · 1.24
Return p.a.
+3.5%
Volatility
2.1%
Max loss
-1.8%Mar 2026

Sharpe vs indices

MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
EBBB
0.33
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
1.6%
Holdings
1,859
As of
Fund holdings
  1. 1JPMORGAN CHAS VAR Mar30 EMTNXS24612346220.18%
  2. 2GOLDMAN SACHS VAR Jul30 EMTNXS34476512020.16%
  3. 3MORGAN STANLE VAR Mar29XS25950285360.16%
  4. 4BANCO SANTAND VAR Apr29XS29087355040.15%
  5. 5MORGAN STANLE VAR Jan32XS32810484990.15%
  6. 6AMAZON.COM IN 3.1% Mar30XS33051687940.15%
  7. 7AXA SA VAR May49 EMTNXS17996116420.15%
  8. 8JPMORGAN CHAS VAR Nov31 EMTNXS27172919700.15%
  9. 9VERIZON COMM VAR Jun56XS32265428610.15%
  10. 10SANOFI SA 1.375% Mar30FR00133243570.15%

Countries

Classified 98.6%
Largest
20.2%United States
Top 3
49.7%
Effective number
9.41 / HHI

Market cap

Weight vs holdings

1.6%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-200
  • Holdings 201+

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.